Matthew S Jeffreys

Title: Innovations of Matthew S Jeffreys in Bryostatin Compounds

Introduction

Matthew S Jeffreys is an accomplished inventor based in King of Prussia, PA (US). He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of bryostatin compounds. With a total of three patents to his name, Jeffreys has demonstrated a commitment to advancing medical science through innovative methods.

Latest Patents

Jeffreys' latest patents focus on the preparation of bryostatin compounds. His methods provide for the synthesis of bryostatin 1 in multi-gram quantities using a low and unprecedented number of convergent synthetic steps from commercially available materials. These methods are scalable and have low estimated material costs, making it feasible to produce enough material to meet clinical needs. Additionally, his patents include a variety of bryostatin analog compounds and prodrug forms, which are synthetically accessible through these innovative methods, along with pharmaceutical compositions that incorporate them.

Career Highlights

Matthew S Jeffreys is affiliated with Leland Stanford Junior University, where he continues to contribute to research and development in his field. His work has not only advanced the understanding of bryostatin compounds but has also opened new avenues for clinical applications.

Collaborations

Jeffreys has collaborated with notable colleagues such as Paul A Wender and Ryan Quiroz. These partnerships have further enriched his research and have led to significant advancements in the field.

Conclusion

Matthew S Jeffreys is a prominent inventor whose work on bryostatin compounds has the potential to impact clinical practices significantly. His innovative methods and collaborative efforts continue to push the boundaries of pharmaceutical research.